Medical Advisory Board
E-mail
Print
PDF

Medical Advisory BoardThe Cure Is Now Medical Advisory Board was established to investigate & communicate the current state of medical science and typical conditions that can realistically be found in medical establishments today. This “barometer” will help our organization identify those fields which are most in need of improvement. The Cure Is Now Medical Advisory Board includes board certified physicians and certified health professionals. Our Medical Advisory Board members are selected as highly respected experts to provide both depth and range of experience in their specialties. The doctors and other professionals that make up the Medical Advisory board help provide the most complete and accurate information possible reflecting the medical field. Members of the Medical Advisory Board provide insight into to health issues, medical conditions, health-care trends and new developments. These findings are shared with the the Science Advisory Board and Committee on Advanced Technology, who in turn evaluate where technological progress, improvements and innovations can be made. The Board of Directors, along with other advisory panels, takes this guidance under advisement and helps determine where research & development efforts should be directed.


Dr. John Schloendorn
Dr. John Schloendorn

Dr. John Schloendorn earned a PhD in Molecular Cell Biology in 2009, after only 3.5 years at Arizona State University (ASU). While still in school, he served as Director of the SENS Foundation Research Center. While leading the ASU/SENS collaborative effort, John supervised a total of 30+ students and technicians engaged in translational research involving enzyme therapies for age-related storage diseases. Four months after his graduation, in the midst of the economic meltdown, John was able to raise seed money for ImmunePath, followed by another venture capital funding round in 2011. John continues to serve as CEO of ImmunePath, which is engaged in the development of embryonic stem cell therapies for oncology and radiation injury. A native of Germany, John holds a GreenCard under the National Interest Waiver, a program designed to retain exceptional scholars with a high anticipated impact on the future competitiveness of the USA. At the young age of 32, John is listed as author of seven PubMed-indexed publications and named as an inventor on eight active patent applications.


Dr. Kamran Fallahpour
Dr. Kamran Fallahpour

Dr. Fallahpour is a Clinical Psychologist and the director of the Brain Resource Center, New York. His clinical practice and research activities are focused on health, psychology, applied neuroscience and computer-human interfaces. Dr. Fallahpour has years of experience in assessment and treatment of various psychological and neuropsychological conditions that have their roots in the brain, the psyche, and physiology. Applying the latest findings from research in health psychology and neuroscience, he has brought together the latest, most effective tools and techniques for a personalized, objective, and integrated approach to assessment and treatment of psychological and neuropsychological disorders. Dr. Fallahpour’s current research includes participation in international trials identifying biomarkers in depression and ADHD, as well as, helping develop one of the largest databases of brain, cognitive, and genomic data across various mental disorders. In addition to clinical and research activities, he has contributed to design and implementation of applications used for physiological monitoring and computer-human interfaces. Such applications are used in research, clinical practice, and cognitive assessment and training. Dr. Fallahpour is also affiliated with Columbia University College of Surgeons as an Instructor in Clinical Psychology at Roosevelt Hospital Center Department of Psychiatry.


Dr. Gary An
Dr. Gary An

Dr. Gary An is an Associate Professor of Surgery and the Co-Director of the Surgical Intensive Care Unit at the University of Chicago. In addition to being an active clinician, he is a Senior Fellow of the Computation Institute at the University of Chicago. He is a graduate of the University of Miami, Florida School of Medicine and did his surgical residency at Cook County Hospital & University of Illinois, Chicago. He was previously a Trauma Surgeon at Cook County Hospital from 1997 to 2003, the Director of the Burn Intensive Care Unit at Cook County Hospital from 2003-2006 and a Trauma Surgeon at Northwestern Memorial Hospital in Chicago from 2006 to 2010. He is a founding member of the Society of Complexity in Acute Illness (SCAI) and is the current president of the Swarm Development Group, one of the original organizations promoting the use of agent-based modeling for scientific investigation. He is the founder and director of the Fellowship in Translational Systems Biology at the University of Chicago. He is member of multiple medical and computer science societies, and serves on the editorial board of several journals.

He has worked on the application of complex systems analysis to sepsis and inflammation since 1999, primarily using agent-based modeling to create mechanistic models of various aspects of the acute inflammatory response. This work has evolved to the use of agent-based models as a means of dynamic knowledge representation to integrate multiple scales of biological phenomenons. The impetus for his work is the recognition that the Translational Dilemma has arisen from a bottleneck in the scientific cycle at the point of experiment and hypothesis evaluation. His research involves the development of: mechanism-based computer simulations in conjunction with biomedical research labs, high-performance/parallel computing architectures for agent-based models, artificial intelligence systems for modular model construction, and community-wide meta-science environments, all with the goal of facilitating transformative scientific research.


Dr. M. A. Greenstein
Dr. M. A. Greenstein

An internationally recognized author, researcher, whole systems thought leader and innovation strategist, GGI Founder & Chief Brainiac, Dr. M. A. Greenstein (Dr. G) has dedicated her life long energy to advancing the art & neuroscience of creative problem-solving. A pioneer in designing futurist and holistic learning systems and an advocate of “brain smart/mind awake” approaches to tapping insight & harnessing problem solving talents, Dr. G founded GGI as a neuro-consulting/design thinking lab to encourage 21st century methods of creative learning and biotech innovation. An internationally recognized AsiaPacific researcher and Fulbright Senior Scholar to Taiwan/China, Dr. G. brings a global understanding of body/mind integration systems and is currently allied with partners in Asia and South America in generating new neurosomatic research and youth training in cognitive and behavioral neuroscience. Dr. G remains an adjunct faculty member at Art Center College of Design, where she innovates applied neuroscience and design thinking curriculum. To learn more about Dr. G and GGI, go to http://greensteininstitute.com.